Introduction
The FORE-SIGHT TM monitor measures absolute cerebral tissue oxygen saturation (S ct O 2 ) of the frontal lobes of the brain, in a non-invasive way, through near-infrared spectroscopy (NIRS) [1] . Its value for early detection of hemodynamic deterioration in the postoperative phase after congenital cardiac surgery has never been examined. In a prospective observational study [2] , 300 mechanically ventilated patients younger than 12 years after cardiac surgery will be monitored with NIRS, in addition to their routine haemodynamic monitoring. The NIRS monitor is blinded to clinicians, and its predictive value to detect predefined critical hemodynamic events will be analysed.
Objectives
To compare S ct O 2 in relationship to the arterial oxygen saturation (S a O 2 ) and central venous oxygen saturations (S cv O 2 ), in children with cyanotic (CC) and noncyanotic cardiopathy (NCC) admitted to the paediatric intensive care unit (PICU) after congenital cardiac surgery.
Methods
The present study is a preliminary report of baseline data and monitored values of the first 136 children included in the abovementioned prospective observational FORE-SIGHT TM study.
Results
The results are summarized in table 1 and table 2 . 83 children were admitted with a CC, 53 with NCC, and 57.3% were boys. Patients in the CC-subgroup had a longer median PICU length of stay, had lower mean arterial blood pressures, and higher haemoglobin levels compared to patients in the NCC-subgroup. Evidently, CC-patients had a lower mean S a O 2 . There was a nonsignificant trend towards lower S cv O 2 and S ct O 2 values in the CC subgroup (which was significant for L-S ct O 2 ). S cv O 2 was significantly lower than S ct O 2 in the CC-subgroup (p=0.002), but not in the NCC-subgroup (p=0.28).
Conclusions
Notwithstanding the lower observed S a O 2 , CC patients are able to preserve brain tissue oxygenation as measured by NIRS, which is significantly higher than their S cv O 2 . The additional predictive value of NIRS in this setting will be assessed in the ongoing Fore-sight study.
Trial Registration
Clinical trial registered with www.clinicaltrials.gov (NCT01706497). 
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